Takeda Pharmaceutical Co (SSE:4502) Institutional Ownership : 38.10% (As of May. 11, 2024)

View and export this data going back to . Start your Free Trial

What is Takeda Pharmaceutical Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Takeda Pharmaceutical Co's institutional ownership is 38.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Takeda Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Takeda Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 99.84%.

Takeda Pharmaceutical Co Institutional Ownership Historical Data

The historical data trend for Takeda Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Institutional Ownership Chart

Takeda Pharmaceutical Co Historical Data

The historical data trend for Takeda Pharmaceutical Co can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	39.70	39.84	39.81	39.86	39.69	38.61	38.78	39.00	37.98	38.10

Takeda Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Takeda Pharmaceutical Co (SSE:4502) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (SSE:4502) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (SSE:4502) Headlines

No Headlines